- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/726 - Glycosaminoglycans, i.e. mucopolysaccharides
Patent holdings for IPC class A61K 31/726
Total number of patents in this class: 423
10-year publication summary
|
45
|
38
|
46
|
20
|
30
|
32
|
24
|
20
|
28
|
20
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Synedgen, Inc. | 63 |
23 |
| The University of North Carolina at Chapel Hill | 2111 |
7 |
| The Regents of the University of California | 20802 |
6 |
| Exthera Medical Corporation | 54 |
6 |
| Seikagaku Corporation | 165 |
6 |
| Jiuzhitang Co., Ltd. | 18 |
5 |
| Rohto Pharmaceutical Co., Ltd. | 414 |
5 |
| Glycologix, Inc. | 7 |
5 |
| Notogen, Inc. | 7 |
5 |
| Société des Produits Nestlé S.A. | 10044 |
4 |
| Centre National de La Recherche Scientifique | 11055 |
4 |
| Altergon S.A. | 68 |
4 |
| Bausch & Lomb Incorporated | 1062 |
4 |
| Ibsa Institut Biochimique S.A. | 316 |
4 |
| Laboratorios Farmaceuticos Rovi, S.A. | 230 |
4 |
| Maruho Co., Ltd. | 95 |
4 |
| University Health Network | 1064 |
4 |
| U.S. Nutraceuticals, L.L.C., DBA Valensa International | 26 |
4 |
| Agency for Science, Technology and Research | 3744 |
3 |
| Duke University | 3181 |
3 |
| Other owners | 313 |